180 Gender differences in clinical presentation and outcome of transcatheter Aortic valve implantation for severe aortic stenosis  by Hayashida, Kentaro et al.
© Elsevier Masson SAS. All rights reserved.
 
56 Archives of Cardiovascular Diseases Supplements (2012) 4, 54-66
(closed-heart in 121, open-heart in 30, and PMC in 12). Mean age was
48±14 years. Valve calcification was present in 62 pts (38%). The mechanism
of restenosis was bilateral commissural fusion.
Results: After PMC, valve area increased from 1.1±0.2 to 1.8±0.3 cm².
Severe mitral regurgitation occurred in 9 pts (5.5%). Good immediate results
(IR) (valve area1.5 cm² with MR2/4) were obtained in 135 pts (83%).
The 18-year rate of good functional results (survival without reintervention
on the mitral valve and in NYHA class I or II) was 19±4%. After good IR, the
rate of good functional results was 58±4% at 10 years and 23±5% at 18 years.
Multivariate predictive factors of poor late functional results were higher ini-
tial NYHA class (p=0.02), initial atrial fibrillation (p<0.001), and higher mean
mitral gradient after PMC (p=0.004).
Conclusion: 1) In selected pts with restenosis after previous mitral com-
missurotomy, PMC provides good IR in the majority of them 2) After good
IR, sustained functional improvement is present in almost one out of 4 pts
after 18 years, enabling reoperation to be deferred in more than half of pts
after 10 years. 3) Predictive factors of late results provide relevant information
for patient selection.
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Background: About 15 to 25% of patients with severe aortic stenosis (AS)
(aortic valve area, AVA1 cm²) have a low transvalvular flow and a low mean
gradient (< 40 mmHg) despite preserved left ventricular ejection fraction
(LVEF). This entity, named paradoxical low flow, low gradient (PLFLG) AS,
was initially described using Doppler-echocardiography. However, some con-
cerns were raised about potential overestimation of the prevalence of this
entity by echo. This study aimed to describe the prevalence and clinical char-
acteristics of patients with PLFLG AS using cardiac catheterization data.
Methods and Results: Between 1994 and 2010, 2005 patients underwent
cardiac catheterization for evaluation of AS severity and identification of cor-
onary artery disease prior to aortic valve replacement (AVR). Of these
patients, we excluded patients with other valvular heart disease or with a
LVEF <50%. Of the remaining 1296. 58% of patients had an AVA1 cm² and
a mean gradient >40 mm Hg (classical severe AS), whereas 23% had an
AVA 1 cm² but a mean gradient <40mm Hg (PLFLG AS); the remaining
16% were considered not having severe AS and 2% had an AVA >1 cm² and
a mean gradient >40 mmHg. In comparison to the patients with Classical
severe AS, those with PLFLG AS were significantly older, more often female,
had lower cardiac output, higher systolic blood pressure, and pulmonary vas-
cular resistance (all p<0.05). The percentage of patients who finally underwent
AVR was significantly lower (85 vs. 95%) and that of patients who had con-
comitant CABG was higher (38 vs. 31%) in patients with PLFLG AS.
Conclusion: This large cardiac catheterization dataset shows that PLFLG
severe AS is a frequent entity that afflicts up to 23% of the patients with
severe AS referred to AVR. These patients had more frequent co-morbidities.
These findings further underlines the importance to correctly identify this
entity so we do not deny surgery to patients with a small AVA and a low gra-
dient despite preserved LVEF.
178
Prospective study of quality of life after surgical treatment of rheuma-
tic valve disease in the young
Dounia Benzarouel [Orateur] , Hanane Ashab, Drissi Boumzera, Mustafa
El Hattaoui
CHU Mohamed VI, Cardiologie, Marrakech, Maroc
The surgical management of valvular heart disease is usually assessed in
terms of mortality, morbidity, operative and post operative that are often inad-
equate. Few studies have investigated the impact of this heavy surgery on
patients quality of life, the aim of our study is to examine the real benefit of
surgical treatment of rheumatic valvular heart disease by assessing the quality
of life before and 3 months after surgery. This is a prospective study per-
foremed on Cardiology and Cardiovascular Surgery departments of University
Hospital Mohamed VI in Marrakech, over a period of five months (May-
October 2010) The study is still continued.
Patiens and methods: We included all patients aged under 40 candidates
for valve replacement surgery for rheumatic valvulopathy. Quality of life was
assessed by validated Arabic version of the SF 36 score.
Results: 52 patients, mean age 33 years (30 women/22 hommes), symp-
tomatic NYHA IV of 75%, atrial fibrillation in 71%. The period of operability
after surgical indication ranged from 6 months to 3 years. It was a mitral dis-
ease in 38%, 36% mitral stenosis and aortic disease in 11% of cases. Analysis
of SF-36 score before surgery is on average 40 on a scale (0-100), spent on
average to 66.4 after surgery and ranged from 45 to 80. Improving quality of
life was concerned mainly moderate activities (items 4-5-7-8). The factors
identified as influencing the quality of life after replacement: the nature of the
valvular disease, its severity, it is an isolated or associated, the dimensions and
left ventricular systolic function preoperatively.
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We suggest that longitudinal left ventricular function assessed by mitral
annular velocities and apical mitral annulus motion would improve after relief of
mitral stenosis and that serial assessment could be used as an index for quantifying
functional changes after percutaneous mitral commissurotomy (PMC).
Methods: Longitudinal left ventricular annular velocities were quantified
by spectral pulsed wave Doppler tissue velocity imaging in 62 patients
(48 women; mean age 45+/–10 years who had isolated mitral stenosis and
were in sinus rhythm. Echocardiography was performed 1 to 24 hours before
PMC and 24 hours, 1 and 3 months after.
We recorded changes in velocities from the lateral and septal corners of the
mitral annulus in early diastole, late diastole, volume and systolic function of
the left and right ventricular, the maximal and minimal volume and the ejec-
tion fraction (EF) of the left atrium by the Simpson method.
Results: After PMC we relieved a decrease in the left atria volume and an
improvement of the left ventricular EF (28.8±12% a 39.20%, p=0.003), an
increase of the left ventricular systolic volume (31.11 vs 52±35 ml, p=0.003)
The peak annular velocity of systolic excursion in ejection and the mitral
annulus motion showed a significant improvement they were respectively at
6.5±1.1 vs 7.9±1.0, p=0.001 and 9.5±1.4 vs 12.6±2, p=0.02). The change in
peak annular velocity in the lateral wall correlated well with improvement in
the mitral valve orifice area by planimetry (r=0.953, p=0.04), and inversely
correlated with the thickness of the mitral leaflet (r=–0.953, p=0.04).
Conclusion: Serial evaluation of changes in mitral annular velocities and
annulus motion by Doppler tissue imaging aids clinical assessment of immediate
improvement in left ventricular function after PMC.This changes are correlated to
the anatomy valve and to the improvement of the left ventricular load.
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Objectives: To clarify the impact of gender difference in transcatheter aortic
valve implantation (TAVI) for high-risk patients with severe aortic stenosis.
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Background: Although TAVI is becoming a mature technique, the impact
of gender difference remains unclear.
Methods: TAVI patients were included prospectively in a dedicated data-
base. The proportion of female patients (131) was similar to male (129). The
Edwards valve (85.4%) and CoreValve (14.6%) were used via the transfem-
oral (65.0%), subclavian (3.1%) or transapical approach (31.9%). All events
were defined by the VARC criteria.
Results: Age was similar (83.1±6.3 years), but women had less coronary
and peripheral disease and previous cardiac surgery, and higher ejection frac-
tion with a lower EuroSCORE (22.3±9.0 vs 26.2±13.0%, p=0.005). Minimal
femoral size (7.74±1.03 vs 8.55±1.34mm, p<0.001), annulus size (20.9±1.4 vs
22.9±1.7mm, p<0.001) and valve size (23.9±1.6 vs 26.3±1.5mm, p<0.001)
were smaller in women. Device success was similar (90.8 vs 88.4%, p=0.516)
despite increased iliac complication (9.0 vs 2.5%, p=0.030). Kaplan-Meier
survival at 1-year was 76% (95%CI, 72-80%) for women vs 65% (95%CI, 60-
69%) for men (log-rank p=0.022).
By multivariate analysis, male gender (HR 1.798: 1.004-3.215, p=0.048),
previous cardiac surgery (HR 2.299: 1.219-4.336, p=0.010), post-procedural
aortic regurgitation (HR 2.261: 1.308-3.909, p=0.004), Transfusion (HR
2.474: 1.319-4.640, p=0.005), acute kidney injury (HR 6.907: 3.085-15.465,
p<0.001), and conversion to surgery (HR 5.147: 1.428-18.550, p=0.012) were
identified as the predictors for long-term mortality.
Conclusions: Female patients have better baseline clinical characteristics
and better survival, and are also identified as an independent predictor of long-
term survival in the TAVI cohort.
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Background: Transcatheter aortic valve implantation (TAVI) is a growing
cardiac intervention, using ionising radiation with deterministic and stochastic
effects for the patient as well as for the medical heart team. Operator radiation
depends on numerous factors, such as distance to the source, fluoroscopy time,
and X ray tube angulation. Lead protection is routinely used for coronary
angiography, but is less suitable for use during TAVI, and areas such as the
hands and eyes are not systematically protected. We aimed to quantify the
radiation dose received by the heart team members during TAVI and evaluate
the role of the position of each member.
Methods: Operator radiation was evaluated by means of small dosimeters
located on the outside of the lead protection at shoulder, knee and hip. We also
measured radiation at the level of the eyes and hands, using small dosimeters that
could be mounted on glasses and rings. The whole team was equipped (3 sur-
geons, 2 interventional cardiologists, 1 nurse and 1 echocardiographer).
Results: 12 TAVI were performed between February and May 2010
(4 apical and 8 femoral access). The most exposed area was the knee for all
members of the team. The most exposed member was the surgeon standing
closest to the X-ray tube, who received a significantly higher dose than all
other team members, and for all areas measured. During a difficult implanta-
tion procedure, we observed an alarmingly high dose at the level of the hand
(2000 μSv) and the eyes (499 μSv) for this surgeon, who does not have pro-
tective glasses and gloves adapted for this procedure at his disposition.
Conclusion: A higher radiation dose was received by the surgeon closest
to the X-ray tube during TAVI. Further to this study, we modified our proce-
dure to reduce the radiation dose as much as possible for the medical team,
with systematic use of lead protection and glasses, and identification of the
fluoroscopy period.
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Objectives: We recently demonstrated the presence of tissue factor (TF),
the main contributor to atherosclerotic plaque thrombogenicity, and thrombin
in diseased valve leaflets. TF may be involved in the mineralization process
of aortic valves by enhancing the generation of the pro-inflammatory
osteopontin (OSP) N-half through thrombin induction. To strengthen our
hypothesis, we evaluated TF expression by cultured valve interstitial cells
(VICs) and studied their ability to generate thrombin in vitro.
Methods: VICs were obtained from explanted aortic valves after collage-
nase digestion. TF activity was measured with a commercial chromogenic
assay under basal conditions and after stimulation with TNF- (10-50 ng/ml;
16h). Thrombin generation capacities of VICs were analyzed using a Cali-
brated Automated Thrombogram assay. A dedicated software program
enabled the calculation of thrombin generation over time. The area under the
curve (ETP) represents the total amount of thrombin generated. The lag time
is the time needed to achieve an explosive burst of thrombin.
Results: The isolated VICs express active TF. Basal TF antigen and
activity varied among valves and were dose-dependently increased after stim-
ulation with TNF-. VICs were able to generate thrombin in vitro, propor-
tional to the amount of cells used for the experiments. TNF- stimulation led
to a shorter lag time (12.6 min vs 10.8 min basal vs stimulated conditions) and
increased both the maximal and total concentration of generated thrombin
(peak: 141nM vs 116 nM; ETP:1034 nM/min vs 1179 nM/min; stimulated vs
unstimulated).
Conclusion: We showed here for the first time that VICs express active TF
and are able to generate thrombin in vitro. TF expression by VICs can be
induced by TNF- stimulation. The concentration of thrombin generated is
proportional to the amount of cells and TF activity. These results strengthen
our hypothesis that TF may play a role in aortic valve mineralization through
thrombin generation.
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Background: Pulmonary hypertension (PHT) in patients with severe aortic
stenosis (AS) is associated with increased morbidity and mortality. In asymp-
tomatic patients, the additive value of exercise (Ex) PHT is unexplored. We
aimed to identify the determinants and impact on outcome of ExPHT in
asymptomatic patients with severe AS.
Method and results: Asymptomatic patients with severe AS (n=106) and
preserved left ventricular (LV) function were prospectively referred to exer-
cise stress echo. Resting and ExPHT were defined as a systolic pulmonary
arterial pressure (SPAP) >50 mmHg and >60 mmHg, respectively. Ex PHT
was more frequent than resting PHT (55% vs. 6%, p<0.0001). Patients with
ExPHT were more frequently male (p=0.035), had significant higher mean
aortic gradient (p=0.04) and longer diastolic filling time (p=0.015) than those
without ExPHT. ExSPAP was correlated with resting aortic mean pressure
gradient and peak aortic velocity (r=0.49 and r=0.48, both p=0.01), with LV
diastolic filling time (r=0.54, p=0.003) and the Ex-induced changes in E/Ea
ratio (r=–0.53, p=0.007). Multivariate logistic regression analysis showed that
only Ex-induced changes in E/Ea ratio (p=0.02) and resting peak aortic
velocity (p=0.007) were independently associated with ExSPAP.
